---
title: "BEAUTYFARM MED received an increase of 61,000 shares by non-executive director Yi Lin"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263615216.md"
description: "Non-executive director Yi Lin of BEAUTYFARM MED increased her holdings by 61,000 shares on October 24, 2025, demonstrating confidence in the company's future development. Meanwhile, the company repurchased 30,000 shares on October 30, 2025, for a total amount of approximately HKD 927,150, with an average price of about HKD 30.91. Since October 15, the company has repurchased 475,000 shares, with a total consideration of approximately HKD 15,069,220. The board believes that the current stock price does not reflect the company's intrinsic value, and the repurchase helps enhance capital market value and shareholder returns"
datetime: "2025-10-30T22:31:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263615216.md)
  - [en](https://longbridge.com/en/news/263615216.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263615216.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263615216.md) | [English](https://longbridge.com/en/news/263615216.md)


# BEAUTYFARM MED received an increase of 61,000 shares by non-executive director Yi Lin

According to the Zhitong Finance APP, BEAUTYFARM MED (02373) announced that its non-executive director, Ms. Yi Lin, purchased a total of 61,000 ordinary shares of the company in the open market using her own funds on October 24, 2025, demonstrating her strong optimism and confidence in the group's future development prospects.

In addition, the company repurchased 30,000 shares of the company on the market on October 30, 2025, with a total transaction amount of approximately HKD 927,150, at an average transaction price of about HKD 30.91 per share. From October 15, 2025, to the date of this announcement, the company has repurchased a total of 475,000 shares, with a total consideration of approximately HKD 15,069,220.

The board of directors believes that the current trading price of the shares does not reflect the intrinsic value of the shares and the actual business prospects of the company. The board believes that the share repurchase reflects the management's strong confidence in the long-term value of the enterprise, which is beneficial for enhancing the group's capital market value and shareholder return capability. This share repurchase is in the overall interest of the company and its shareholders

### 相關股票

- [BEAUTYFARM MED (02373.HK)](https://longbridge.com/zh-HK/quote/02373.HK.md)

## 相關資訊與研究

- [Beauty Farm Medical & Health Industry, Inc. (2373) Gets a Buy from Guotai Haitong](https://longbridge.com/zh-HK/news/281131476.md)
- [Trump to sign order to pay tens of thousands of DHS employees](https://longbridge.com/zh-HK/news/281556389.md)
- [The Trump administration’s antitrust honeymoon is over](https://longbridge.com/zh-HK/news/281398996.md)
- [ASIA COFFEE-Domestic prices edge lower in Vietnam amid slow trade, thin demand](https://longbridge.com/zh-HK/news/281490266.md)
- [07:35 ETLucky Energy Expands Its Beverage Line with SLUSH, Introducing Three New Flavors in a 12-oz Sleek Can](https://longbridge.com/zh-HK/news/281516216.md)